CRL  valuation analysis

Basics
Name: Charles River Laboratories International Inc
Description: Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 03, 2021
Market cap: $19.05B (366th)
Sales(TTM): $3.43B (598th)
Earnings(TTM): $403.20M (560th)

Value
FFER: 3.15 (why)
Actual price: $369.56
FFEThis is Charles River Laboratories International Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $117.24
Quantile: CRL is very expensive given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Charles River Laboratories International Inc
"Diagnostics & Research" industry
Sales / MarketCap
Charles River Laboratories International Inc
"Diagnostics & Research" industry
Book / MarketCap
Charles River Laboratories International Inc
"Diagnostics & Research" industry
Equity / Assets
Charles River Laboratories International Inc
"Diagnostics & Research" industry